EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis

Zhimin Zhou, Yuhong Xie, Qianru Wei, Xinyue Zhang, Zhihao Xu

Frontiers in Cell and Developmental Biology · 16.10.2024 · 12

DOI: 10.3389/fcell.2024.1470875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 16.10.2024. Verfasst von Zhimin Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a prevalent chronic pulmonary fibrosis disease characterized by alveolar epithelial cell damage, fibroblast proliferation and activation, excessive extracellular matrix deposition, and abnormal epithelial-mesenchymal transition (EMT), resulting in tissue remodeling and irreversible structural distortion. The mortality rate of IPF is very high, with a median survival time of 2–3 years after diagnosis. The exact cause of IPF remains unknown, but increasing evidence supports the central role of epigenetic changes, particularly microRNA (miRNA), in IPF. Approximately 10% of miRNAs in IPF lung tissue exhibit differential expression compared to normal lung tissue. Diverse miRNA phenotypes exert either a pro-fibrotic or anti-fibrotic influence on the progression of IPF. In the context of IPF, epigenetic factors such as DNA methylation and long non-coding RNAs (lncRNAs) regulate differentially expressed miRNAs, which in turn modulate various signaling pathways implicated in this process, including transforming growth factor-β1 (TGF-β1)/Smad, mitogen-activated protein kinase (MAPK), and phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) pathways. Therefore, this review presents the epidemiology of IPF, discusses the multifaceted regulatory roles of miRNAs in IPF, and explores the impact of miRNAs on IPF through various pathways, particularly the TGF-β1/Smad pathway and its constituent structures. Consequently, we investigate the potential for targeting miRNAs as a treatment for IPF, thereby contributing to advancements in IPF research.

Schlagwörter

Stichwörter der Autor:innen

IPFMAPKPI3K/AKTTGF-β1/SmadmiRNA

Autor:innen und Institutionen

  • The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.

Zitieren

APA

Zhou, Z., Xie, Y., Wei, Q., Zhang, X., & Xu, Z. (2024). Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1470875

Vancouver

Zhou Z, Xie Y, Wei Q, Zhang X, Xu Z. Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1470875

BibTeX
@article{Zhou2024,
  author = {Zhou, Zhimin and Xie, Yuhong and Wei, Qianru and Zhang, Xinyue and Xu, Zhihao},
  title = {Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1470875}
}
Kostenlos starten →